MRNA Profit Margins
Gross, Operating & Net Margin Analysis for Moderna Inc
Margin Quality
Weak
Current Profit Margins
Gross Margin
55.3%
$1.08B gross profit
Operating Margin
-158.1%
$-3074000000.00 operating income
Net Profit Margin
-145.2%
$-2822000000.00 net income
5-Year Margin Trends
What Margins Indicate About MRNA
Business Quality
High gross margins above 50% suggest Moderna Inc has strong pricing power and competitive advantages that allow premium pricing.
Operational Efficiency
Declining operating margins may indicate rising costs, competitive pressures, or investments in growth.
Profitability
Negative net margins indicate the company is currently unprofitable and burning cash.
Investment Implications
Mixed margin trends require deeper analysis to understand underlying business dynamics and sustainability.
Understanding Profit Margins
Gross Margin
(Revenue - Cost of Goods Sold) / Revenue. Measures pricing power and production efficiency before operating expenses.
Operating Margin
Operating Income / Revenue. Shows profitability from core operations after all operating expenses but before interest and taxes.
Net Profit Margin
Net Income / Revenue. The bottom line - shows how much profit the company keeps from each dollar of revenue after all expenses.
Analyze MRNA Profitability
Get complete financial analysis with profitability trends, ROE, ROIC, and more
Frequently Asked Questions
What is MRNA's profit margin?
MRNA (Moderna Inc) has a net profit margin of -145.2%, meaning the company keeps $-1.4516460905349795 in profit for every dollar of revenue. This represents a change from the previous year's net margin of -110.0%.
What is MRNA's gross margin?
MRNA's gross margin is 55.3%. Gross margin measures the percentage of revenue remaining after subtracting the cost of goods sold. A high gross margin like this indicates strong pricing power and efficient production.
What is MRNA's operating margin?
MRNA has an operating margin of -158.1%. Operating margin shows profitability after operating expenses but before interest and taxes. This metric helps investors understand how efficiently Moderna Inc manages its operations.
Are MRNA's profit margins good?
MRNA's margins are considered weak. When evaluating margins, it's important to compare against Biotechnology peers, as different sectors have structurally different margin profiles.
How do profit margins affect MRNA stock?
Profit margins are a key indicator of MRNA's business quality and competitive position. The current margins should be evaluated alongside growth rates and return on capital to assess overall business quality. Expanding margins often lead to stock price appreciation, while contracting margins can signal competitive pressures.
What drives MRNA's profit margins?
MRNA's profit margins are influenced by several factors: pricing power vs competitors, operational efficiency, scale advantages, input costs (materials, labor), Biotechnology-specific dynamics, and management execution. The significant expansion in gross margin suggests changes in these underlying drivers.
Disclaimer: Margin analysis is based on reported financial statements and should be compared to industry peers for context. Different sectors have structurally different margin profiles. This information is for educational purposes only and should not be considered financial advice.